Posted Apr. 2, 2014 at 9:31 a.m.

Premium Lock Drug giant Baxter acquires Chapel Hill firm for $70M

Published: 2014-04-02 09:31:59
Updated: 2014-04-02 09:31:59

Heart research heart research

Baxter International is acquiring Chapel Hill-based Chatham Therapeutics to gain control of gene-based therapy technology focused on hemophilia. The deal includes a $70 million upfront payment. Additional payments could be made based on development, regulatory and commercial milestones....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders